Global Teleradiology Market 2016-2020

2016-05-12
Price :
Published : May-2016
No. of Pages : 85

The healthcare industry is witnessing phenomenal changes owing to increased adoption of digital health platforms such as mobile health, telehealth, EMR, and other wireless technologies. Digital health platforms have become essential elements in every healthcare organization, as they enable remote monitoring of patients, increase healthcare delivery efficiencies, improve access to electronic health information, and improve the quality of healthcare services along with reducing costs.

Teleradiology is a comprehensive part of telehealth services. Teleradiology refers to the electronic transmission of radiological images via the internet for a second opinion or emergency services. Radiological images are obtained from techniques such as X-ray, CT, ultrasound, MRI, and nuclear imaging. Teleradiology services use advanced information and communication tools to deliver radiology and consultation services for effective diagnosis and treatment. Teleradiology is a cost-effective and time saving tool in diagnosing and treating patients in emergency situations. It bridges the gap between the demand and supply of expert radiologists worldwide.

The analysts forecast Global Teleradiology Market to grow at a CAGR of 15.72% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the Global Teleradiology Market for 2016-2020. To calculate the market size, we consider revenue generated from the spending on teleradiology technologies such as hardware, software, and telecom and networking.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Teleradiology Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Agfa Healthcare
  • Siemens Healthcare
  • StatRad
  • vRad

Other prominent vendors

  • Argus Radiology
  • Cybernet Medical
  • Everlight Radiology
  • Franklin and Seidelmann
  • Fujifilm Medical Systems
  • GE Healthcare
  • Medica Reporting
  • Merge Healthcare
  • NightHawk Radiology
  • ONRAD
  • Philips Medical Systems
  • Radiology Reporting Online (RRO)
  • Radisphere National Radiology Group
  • RamSoft
  • Sectra Imtec
  • TeleDiagnosys Services
  • Telemedicine Clinic
  • Teleradiology Solutions

Market driver

  • Advancements in imaging technology
  • For a full, detailed list, view our report

Market challenge

  • Lack of common standards
  • For a full, detailed list, view our report

Market trend

  • Emergence of thin client 3D viewers
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Venezuela

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela Summary Venezuela ranked 187 out of 190 countries in ease of doing business. In July 2017, rating firm Standard & Poor's downgraded Venezuela's economy to CCC with a negative outlook. Moody's also downgraded its rating to Caa3 with a negative outlook, while Fitch rated it at CCC with a negative outlook. Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers. The value of the market was US$12.6 Billion in 2015, having increased from US$5.7 Billion in 2009, at a Compound Annual Growth Rate (CAGR) of 14.1%. Drug prices in Venezuela are ......
$1995

Hemorrhage Global Clinical Trials Review, H2, 2017

Hemorrhage Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhage Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Hepatitis C Global Clinical Trials Review, H2, 2017

Hepatitis C Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatitis C Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis C clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis C. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2017

Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2017" provides an overview of Herpes Zoster (Shingles) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - ......
$2500

Hemorrhagic Fever Global Clinical Trials Review, H2, 2017

Hemorrhagic Fever Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhagic Fever Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhagic Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhagic Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Hepatitis D Global Clinical Trials Review, H2, 2017

Hepatitis D Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatitis D Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis D clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis D. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2017

Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2017" provides an overview of Heterozygous familial hypercholesterolemia (heFH) clinical trials scenario. This report provides top line data relating to the clinical trials on Heterozygous familial hypercholesterolemia (heFH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing......
$2500

Hemorrhagic Shock Global Clinical Trials Review, H2, 2017

Hemorrhagic Shock Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhagic Shock Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhagic Shock clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhagic Shock. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Hepatitis E Global Clinical Trials Review, H2, 2017

Hepatitis E Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatitis E Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis E clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis E. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Hemorrhoids Global Clinical Trials Review, H2, 2017

Hemorrhoids Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhoids Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhoids clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhoids. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500